We are pleased to announce that by the end of this month there will be 5 clinical sites open across the USA that are approved to enroll patients to our Phase II trial for treatment of advanced pancreatic cancer.

 These sites include Vanderbilt University Medical Center (Nashville, TN), Virginia Mason Medical Center (Seattle, WA), Virginia Cancer Specialists (Fairfax, VA), Florida Hospital Tampa (Tampa, FL) and HonorHealth (Scottsdale, AZ). Further information on the trial and criteria for enrollment eligibility can be obtained at www.clinicaltrials.gov and searching under “PBI-05204”.